cefixime has been researched along with Maxillary Sinusitis in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Maxillary Sinusitis: Inflammation of the NASAL MUCOSA in the MAXILLARY SINUS. In many cases, it is caused by an infection of the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; or STAPHYLOCOCCUS AUREUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cefixime was effective in the treatment of bacterial sinus infections in adults and was well tolerated." | 6.67 | Evaluation of cefixime in the treatment of bacterial maxillary sinusitis. ( Edelstein, DR; Kimmelman, CP; Kohlbrenner, VM; Kohut, RI; Marinaccio, AT; Matthews, BL; McCaffrey, TV; Parnes, SM; Rapp, M; Rybak, LP, 1993) |
| "Cefixime was effective in the treatment of bacterial sinus infections in adults and was well tolerated." | 2.67 | Evaluation of cefixime in the treatment of bacterial maxillary sinusitis. ( Edelstein, DR; Kimmelman, CP; Kohlbrenner, VM; Kohut, RI; Marinaccio, AT; Matthews, BL; McCaffrey, TV; Parnes, SM; Rapp, M; Rybak, LP, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, BL | 1 |
| Kohut, RI | 1 |
| Edelstein, DR | 1 |
| Rybak, LP | 1 |
| Rapp, M | 1 |
| McCaffrey, TV | 1 |
| Kimmelman, CP | 1 |
| Parnes, SM | 1 |
| Marinaccio, AT | 1 |
| Kohlbrenner, VM | 1 |
1 trial available for cefixime and Maxillary Sinusitis
| Article | Year |
|---|---|
Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria | 1993 |